Trospium Chloride Tablet, Film Coated
Product Images NDC 0574-0145

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Trospium Chloride (NDC 0574-0145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Padagis Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

7r2rc Trospium Chloride Tablets

Label for Trospium Chloride Tablets 20 mg by Padagis US LLC, showing the NDC 0574-0145-60. The label indicates the product contains 60 film-coated oral tablets with 20 mg of trospium chloride each. Storage instructions specify 20° to 25°C. The label includes the Perrigo logo and manufacturing details from Perrigo Minneapolis.*

FDA Label Image

Image 01

Chemical structure of trospium chloride, showing the molecular arrangement including a quaternary ammonium ion with chloride and associated bicyclic and aromatic groups.*

FDA Label Image

Image 02

A line graph depicting plasma concentration (ng/mL) versus time (hours post-dose) for a drug, showing the concentration peaking around 2 hours after dosing and gradually declining to near zero by 48 hours post-dose. Error bars indicate variability at each time point.*

FDA Label Image

Image 03

A line graph comparing the mean change (±SE) over weeks of treatment between placebo and trospium chloride tablets. The horizontal axis represents weeks of treatment at 1, 4, and 12 weeks, and the vertical axis shows mean change values. Trospium chloride tablets demonstrate greater negative mean change than placebo with significant differences (p < 0.001) at weeks 4 and 12.*

FDA Label Image

Image 04

A line graph comparing the mean change over time between Placebo (N=256) and Trospium Chloride Tablets (N=253) across 1, 4, and 12 weeks of treatment. The y-axis represents mean change with error bars, and p-values are indicated at each time point to show statistical significance.*

FDA Label Image

Image 05

A line graph comparing mean change over weeks of treatment between placebo and Trospium Chloride tablets groups. The x-axis represents weeks of treatment (1, 4, 12), and the y-axis shows mean change with error bars (±SE). Trospium Chloride shows a greater decrease in mean values at each time point compared to placebo, with p-values indicating statistical significance.*

FDA Label Image

Image 06

A line graph displaying the mean change over weeks of treatment comparing Trospium Chloride tablets (20 mg) to placebo. The x-axis represents treatment weeks (1, 4, and 12), and the y-axis shows mean change values, with Trospium Chloride tablets showing greater decreases than placebo at each time point, accompanied by significance markers (p<0.001).*

FDA Label Image

Serialization Template

A text panel containing placeholders for product identification information. It includes fields for serial number (S/N), lot number, and expiration date (Exp) of the product. The panel is formatted with bracketed prompts indicating where specific product details should be inserted.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.